Whitebox Advisors’s Longevity Health Holdings, Inc. Common Stock XAGE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q2
Sell
-2,500
Closed -$761K 465
2023
Q1
$761K Hold
2,500
0.03% 211
2022
Q4
$744K Hold
2,500
0.02% 342
2022
Q3
$731K Buy
+2,500
New +$729K 0.02% 425
2022
Q2
Sell
-2,500
Closed -$731K 939
2022
Q1
$731K Hold
2,500
0.01% 439
2021
Q4
$722K Buy
+2,500
New +$729K 0.01% 441

Other funds holding XAGE

Whitebox Advisors's XAGE Position: Q2 2023 in Review

Whitebox Advisors sold out of Longevity Health Holdings, Inc. Common Stock (XAGE) in Q2 2023, closing a stake of 2,500 shares — an estimated $761K sold.

Whitebox Advisors first reported a position in XAGE in Q4 2021 and held it in 5 quarters. The position peaked at $761K in Q1 2023. 35 funds tracked by Wall St. Rank hold XAGE as of Q2 2023.

  • Whitebox Advisors reported no remaining Longevity Health Holdings, Inc. Common Stock position as of Q2 2023 after selling out during the quarter.
  • Whitebox Advisors sold 2,500 Longevity Health Holdings, Inc. Common Stock shares in Q2 2023, an estimated $761K.
  • Whitebox Advisors first reported a position in Longevity Health Holdings, Inc. Common Stock in Q4 2021 and held it in 5 quarters.
  • Whitebox Advisors's Longevity Health Holdings, Inc. Common Stock position peaked at $761K in Q1 2023.
  • 35 funds tracked by Wall St. Rank held Longevity Health Holdings, Inc. Common Stock as of Q2 2023.

Based on Whitebox Advisors's 13F filing for Q2 2023, filed 14 Aug 2023.